ArticleBMC infectious diseases2025
Molecular epidemiology of high-risk human papillomavirus infection and its predictive factors among women living with HIV in Northeast Ethiopia: a facility-based cross-sectional study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prevalence of cervical human papillomavirus infections and cytological abnormalities in asymptomatic women living with HIV in Addis Ababa, Ethiopia.Scientific reports · 2026Article
- High-risk human papillomavirus positivity and associated factors among women living with HIV in public health facilities of Mekelle, Northern Ethiopia.Infectious agents and cancer · 2026Article
- Vaginal Microbiota Composition and HPV Genotype-Specific CIN2+ Risk: A Cross-Sectional Study.Diagnostics (Basel, Switzerland) · 2026Article
- High-risk human papillomavirus and HBV, HCV, and T. pallidum association among women living with HIV in selected health facilities of Mekelle, Tigray, Northern Ethiopia.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus is the most widespread sexually transmitted virus. At least 14 HPV genotypes have been defined as high-risk human papillomavirus types. HPV types 16 and 18 are the two most common high-risk types, contributing to 70% of cervical cancer. The persistence of high-risk HPV infection is linked with weakened immunity.
objectiveThis study aims to determine the molecular epidemiology of high-risk cervical human papillomavirus infection and associated factors among women living with HIV attending public health facilities in Dessie and Kombolcha cities, northeast Ethiopia.
methodsA facility-based cross-sectional study was employed from May to July 2024 at public health facility antiretroviral clinics in Dessie and Kombolcha cities, involving 386 women living with HIV. Participants were recruited using systematic random sampling. Socio-demographic and clinical data were collected using semi-structured questionnaires. Cervical swab samples were collected using Abbott cervi-collect specimen collection kit and high-risk HPV analyzed using real-time DNA polymerase chain reaction with the Abbott molecular system. The data were analyzed with SPSS version 26.0. Logistic regression analysis was utilized to identify associated factors, and then variables with a p-value ≤ 0.05 were considered as statistically significant.
resultsThe overall prevalence of hrHPV infections among study participants was 28.8% [111/386, (95% CI: 24.9, 33.2). The frequently detected genotypes were HPV 16 (27%), HPV 18 (15.3%), and non-16/18 hrHPV (47.7%). In multivariable analysis, the factors independently associated with hrHPV were the number of lifetime sexual partners ≥ 3 (AOR = 2.58, 95% CI: 1.34, 4.99), failure to use a condom during sex (AOR = 1.99, 95% CI: 1.18, 3.34), history of sexually transmitted infections (AOR = 2.12, 95% CI: 1.24, 3.62), duration of Antiretroviral Treatment (ART) < 2 years (AOR = 2.88, 95% CI: 1.61, 5.16), CD4 count < 350/mm3 (AOR = 2.35, 95% CI: 1.34, 4.12), and HIV viral load > 50 copies/ml (AOR = 2.97, 95% CI: 1.70, 5.20).
conclusionThe study revealed a significantly higher prevalence of hrHPV among HIV-positive women in Dessie and Kombolcha cities. The non-16/18 hrHPV genotype was the more frequent compared to HPV 16 and 18. Predictive factors for hrHPV infection included multiple sexual partners, non-use of condoms, history of sexually transmitted infections, short duration on ART, low CD4 counts, and high viral loads. To reduce this risk, ART programs should incorporate cervical cancer screening, promote HPV vaccination, and strengthen sexual health education.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.